Indicated for the treatment of adult patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or patients who do not agree to receive these agents. Efficacy data are mainly based on patients with liposarcoma and leiomyosarcoma.

Manufacturer – PHARMA SEA
Specialty – Oncology
Active principle – Trabectedine